Prevalence of Diabetic Neuropathy and Its Rrisk Factors in Diabetic Patients Referred to the Golestan Hospital Diabetes Clinic during 1393-95

Document Type : Original Article

Authors

1 Diabetes research center, Health research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

2 Diabetes research center, Health research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

3 Department of Internal Medicine, Imam Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

10.32592/JSMJ.22.2.258

Abstract

Background and Objectives Diabetes mellitus is a widespread metabolic disease, with increasing rates and numerous complications worldwide. Nervous system disorders are common complications of diabetes, with around half of diabetics eventually developing neuropathy. Diabetic neuropathy leads to consequences, such as recurrent infections of the lower limbs, diabetic foot ulcers and subsequent amputations. Considering the numerous problems caused by diabetic neuropathy and to contribute to the improvement of prevention and control strategies, this study was conducted to determine the prevalence of diabetic neuropathy in diabetic patients and its risk factors. Subjects and Methods This cross-sectional study was part of a retrospective study (ADFC) conducted on 605 patients with type 2 diabetes referred to Ahvaz Golestan Hospital from 2014 to 2016. The incidence of diabetic neuropathy was assessed in these patients, and the risk factors for developing neuropathy were examined using a checklist and physical examination. The data were then analyzed using SPSS software version23. Results Of 605 patients examined in this study, 213 (35.2%) had diabetic neuropathy. Of these 213 participants, (51%) were women and (49%) men. In the univariable analysis, older age, male gender, longer duration of diabetes, lower education level and smoking were significantly associated with neuropathy, but in the univariable analysis only smoking and duration of diabetes remained in the model with significant relationship (p= 0.005 and <0.0001, respectively). Conclusion Diabetic neuropathy is a common and widespread complication of diabetes. Through early diagnosis and control of risk factors, efforts should be made to reduce this complication in order to minimize its numerous personal, social and financial consequences. In this study, the prevalence of neuropathy was high. In addition, diabetes duration and smoking were defined as major risk factors. It is therefore recommended that neuropathy screening and patient education (on blood glucose control, foot self-care, smoking cessation) be given greater consideration in our region.

Keywords

Main Subjects

References

[1] Ponomarev AD, Sazanova GY, Kunitsyna MA, Terina LM, Vojteshak AA. Analysis of the health status of patients with type 1 and type 2 diabetes mellitus living in urban and rural areas of the Saratov region (according to the data of the federal register of patients with diabetes mellitus). Diabetes mellitus. 2022 Aug 22;25(4):313-21
[2] Hariri S, Rahimi Z, Hashemi-Madani N, Mard SA, et al. Prevalence and determinants of diabetes and prediabetes in southwestern Iran: the Khuzestan comprehensive health study (KCHS). BMC Endocr Disord. 2021;21(1):135. [DOI: 10.1186/ s12902-021-007]
[3] DK M. overview-of-medical-care-in-adults-with-diabetes mellitus: up to date; 2018. Available from: https://www.uptodate.com/contents/overview-of-medical-care-in-adults-with-diabetes , mellitus? search=diabetes %20 complications & source =search _result& selected Title=1~150 &usage _type =default& display _rank=1.
[4] Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes care. 1992;15(7):815-9. [DOI: 10.2337/diacare.15.7.815] [PMID]
[5] Feldman E L. Epidemiology and classification of diabetic neuropathy. Up To Date; 2018. [Link]
[6] Dyck PJ, Kratz K, Karnes J, Litchy WJ, Klein R, Pach J, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort The Rochester Diabetic Neuropathy Study. Neurology. 1993;43(4):817-24. [DOI: doi: 10.1212/wnl.43.4.817] [PMID]
[7] Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Ther. 2008;120(1):1-34. [DOI: 10.1016/j.pharmthera.2008.05.005] [PMID] [PMCID]
[8] Sobhani S, Asayesh H, Asayesh H, Sharifi F, et al. Prevalence of diabetic peripheral neuropathy in Iran: A systematic review and meta-analysis. J Diabetes Metab Disord. 2014;13(1):97. [DOI: 10.1186/s40200-014-0097-y] [PMID] [PMCID]
[9] Humphrey LL, Palumbo PJ, Butters MA, Hallett JW, Chu C-P, O'Fallon WM, et al. The Contribution of None—Insulin-Dependent Diabetes to Lower-Extremity Amputation in the Community. Arch Intern Med. 1994;154(8):885-92. [PMID]
[10] Yazdanpanah L, Shahbazian H, Nazari I, Arti HR, Ahmadi F, Mohammadianinejad S E, Cheraghian B, Latifi S M. Prevalence and related risk factors of diabetic foot ulcer in Ahvaz, south west of Iran. Diabetes Metab Syndr. 2018;12(4):519-524. [DOI: 10.1016/j.dsx.2018.03.018] [PMID]
[11] Leese GP, Reid F, Green V, McAlpine R, Cunningham S, et al. Stratification of foot ulcer risk in patients with diabetes: a population-based study. International Journal of Clinical Practice. 2006;60(5):541-5. [DOI: 10.1111/j.1368-5031.2006.00899.x]
[12] Yovera-Aldana M, Velásquez-Rimachi V, Huerta-Rosario A, et al. Prevalence and incidence of diabetic peripheral neuropathy in Latin America and the Caribbean: A systematic review and meta-analysis. PLoS One. 2021;16(5):e0251642. [DOI: 10.1371/journal.pone.0251642] [PMID] [PMCID]
[13] Tabatabai Molazi Ezra, Mohajeri Tehrani Mohammad Reza, Madani Seyed Pejman, Heshmat Ramin, Ardeshir Larijani Mohammad Baqer, Prevalence of factors affecting the occurrence of peripheral neuropathy in diabetic patients. Number: 3 (series 33) Page: 241-248.
[14] Taheri H, Sarhadi E, Peyvand M, Hashemzehi Gonaki Z. [Prevalence and Severity of Neuropathy in Patients with Type II Diabetes in Zahedan, Iran (Persian)]. J Diabetes Nurs. 2020; 8(2):1096-1104. [Link]
[15] Andrei Cristian B, Amorin Remus P. Diabetic Neuropathy Prevalence and Its Associated Risk Factors in Two Representative Groups of Type 1 and Type 2 Diabetes Mellitus Patients from Bihor County. Maedica (Bucur). 2018;13(3):229–234. [DOI: 10.26574/maedica .2018.13.3.229] [PMID] [PMCID]
[16] Pfannkuche A, Alhajjar A, Ming A, Walter I, Piehler C, Mertens PR. Prevalence and risk factors of diabetic peripheral neuropathy in a diabetics cohort: Register initiative “diabetes and nerves”. Endocrine and Metabolic Science. 2020;1(1-2):100053. [DOI: 10.1016/j.endmts.2020.100053]
[17] Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. Diabetes. 1988;37(4):476-81. [PMID]
[18] Al – Mahroos F, Al – Roomi K. Diabetic, neuropathy, Foot ulceration, Peripheral vascular Disease and potential risk factors among patients with diabetes in Bahrain: a nationwide primary care diabetes clinic – based study. Ann Saudi Med. 2007;27(1):25-31. [DOI: 10.5144/0256-4947.2007.25] [PMID] [PMCID]
[19] Boyko EJ, Ahroni JH, Stensel B, Forsberg RC, Davignon DR, Smith DG. Prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care. 1999;22(7):1036-42. [DOI: 10.2337/diacare.22.7.1036] [PMID]
[20] Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify people at high risk for diabetic foot ulcer eration: a prospective multicenter trial. Diabetes Care. 2000;23(5):606-11. [DOI: 10.2337/diacare. 23.5.606] [PMID]
[21] Bennett PJ, Stocks AE, Whittam DJ. Analysis of risk factors for neuropathic foot ulceration in diabetes mellitus. J Am Podiatr Med Assoc. 1996;86(3):112-6. [DOI: 10.7547/8750 7315-86-3-11] [PMID]
[22] Carole Clair ,Marya J. Cohen, , Florian Eichler, Kevin J. Selby, , Nancy A. Rigotti, The Effect of Cigarette Smoking on Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis J Gen Intern Med. 2015;30(8):1193-203. [DOI: 10.1007/s11606-015-3354-y] [PMID] [PMCID]
[23] Mohammadianinejad SE, Shahbazian HB, Kashipazha D, Karimi M, Oghbaei M, Shalilahmadi D, Mashhadi Zadeh N, Nezhad Salami MR. [Risk Factors Associated with Diabetic Neuropathy in Type 2 C Patients Referred to Diabetic Clinic of Golestan Hospital, Ahvaz, Iran (Persian)]. Jundishapur Scientific Medical Journal. 2013;12(2):141-7. [Link]
[24] Prasto Baharond, H., Habib Moazzami Godarzi, Mohammad Marifzadeh, Prevalence of peripheral neuropathy in patients with diabetes referred to Khorram Abad diabetes center in 2014, scientific-research quarterly of Lorestan University of Medical Sciences, 17th period / number 2 / summer 94 / machine gun 6
Jundishapur Scientific Medical Journal
Volume 22, Issue 2 - Serial Number 143
May and June 2023
Pages 258-267

Files

History

  • Receive Date: 28 June 2022
  • Revise Date: 14 December 2022
  • Accept Date: 14 December 2022

Share

How to cite

Statistics